Classic bladder exstrophy and adenocarcinoma of the bladder: Methylome analysis provide no evidence for underlying disease-mechanisms of this association.


Journal

Cancer genetics
ISSN: 2210-7762
Titre abrégé: Cancer Genet
Pays: United States
ID NLM: 101539150

Informations de publication

Date de publication:
06 2019
Historique:
received: 22 05 2018
revised: 27 03 2019
accepted: 29 05 2019
entrez: 13 7 2019
pubmed: 13 7 2019
medline: 7 3 2020
Statut: ppublish

Résumé

The bladder exstrophy-epispadias complex (BEEC) represents the severe end of uro-rectal malformation spectrum involving aberrant embryonic morphogenesis of the cloacal membrane and the urorectal septum. The most common form of BEEC is isolated classic bladder exstrophy (CBE). Long-term complications in CBE are malignancies of the bladder with 95% of them being adenocarcinomas. Since CBE and adenocarcinoma of the bladder are rare entities, their frequent co-occurrence suggests a common etiology. Recent studies suggest that promoter methylation of various genes play a crucial role during the phenotypical morphogenesis of adenocarcinomas of urinary bladder. To examine, whether epigenetic processes such as DNA methylation patterns are potentially associated with CBE, we performed Illumina 450 K methylation arrays in blood (n = 10) and tissue samples (n = 2) of CBE patients and healthy matched controls (n = 12). In our analysis, we found total lack of methylation in the blood and methylation differences were restricted to 10 CpG sites in the tissue samples. In comparison to other bladder anomalies, CBE tissue methylation profiles differ from those of adenocarcinoma, adenocarcinoma with CBE, urothelial carcinoma and urachal carcinoma. In this preliminary study, we did not provide any strong evidence of major DNA methylation alterations which would be suggestive for strong underlying epigenetic mechanism. However, larger studies are required to provide more robust statistical evidence to exclude smaller effects in the tissues.

Identifiants

pubmed: 31296310
pii: S2210-7762(18)30279-5
doi: 10.1016/j.cancergen.2019.05.004
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
LIM-Homeodomain Proteins 0
PLAGL1 protein, human 0
Transcription Factors 0
Tumor Suppressor Proteins 0
insulin gene enhancer binding protein Isl-1 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18-20

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Amit Sharma (A)

Department of Neurology, University Clinic Bonn, Sigmund-Freud Str. 25, D-53127 Bonn, Germany; Department of Ophthalmology, University Clinic Bonn, Bonn, Germany. Electronic address: amit.sharma@ukbonn.de.

Holger Fröhlich (H)

Bonn-Aachen International Center for IT, University of Bonn, Germany.

Rong Zhang (R)

Institute of Human Genetics, University Hospital of Bonn, Bonn, Germany; Department of Genomics, Life & Brain Center, Bonn, Germany.

Anne-Karoline Ebert (AK)

Department of Urology and Paediatric Urology, Ulm University, Ulm, Germany.

Wolfgang Rösch (W)

Department of Paediatric Urology, Clinic St. Hedwig, University Medical Center Regensburg, Regensburg, Germany.

Henning Reis (H)

Faculty of Medicine, Institute of Pathology, University Duisburg-Essen, Essen, Germany.

Glen Kristiansen (G)

Institute of Pathology, University Hospital Bonn, Bonn, Germany.

Jörg Ellinger (J)

Department of Urology, University Hospital Bonn, Bonn, Germany.

Heiko Reutter (H)

Institute of Human Genetics, University Hospital of Bonn, Bonn, Germany; Department of Genomics, Life & Brain Center, Bonn, Germany; Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH